NCT05267704

Brief Summary

The purpose of this study is to assess the use of virtual reality (VR) as an adjunct or alternative to pharmacologic sedation in pediatric patients undergoing renal biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

October 11, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

March 12, 2026

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

October 7, 2021

Results QC Date

November 7, 2025

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Who "Strongly Agreed" They Would Recommend VR to Others Undergoing Similar Procedures

    Acceptability of VR as non-pharmacologic sedation was assessed based on a team-made Likert scale survey given to patients and parents (Likert scale, with 1 = "strongly disagree" as most dissatisfied with VR experience and 5 = "strongly agree" as most satisfied with VR experience and a better perceived outcome

    From arrival to procedural room to completion of procedure (~30 minutes)

  • Number of Parents Who "Agreed" or "Strongly Agreed" They Would Recommend VR to Others Undergoing Similar Procedures

    Acceptability of VR as non-pharmacologic sedation was assessed based on a team-made Likert scale survey given to patients and parents (Likert scale, with 1 = "strongly disagree" as most dissatisfied with VR experience and 5 = "strongly agree" as most satisfied with VR experience and a better perceived outcome

    From arrival to procedural room to completion of procedure (~30 minutes)

Secondary Outcomes (2)

  • Mean Difference in Self-reported Procedural Anxiety (Change in Childhood Anxiety Meter)

    From arrival to procedural room to completion of procedure (~30 minutes)

  • Mean Difference in Self-reported Procedural Anxiety (Change in Child Fear Scale)

    From arrival to procedural room to completion of procedure (~30 minutes)

Study Arms (1)

VR Arm

EXPERIMENTAL

Pediatric patients age 5-17 using the VR headset during renal biopsy.

Device: Oculus Go Virtual Reality Headset

Interventions

VR headset displaying preselected game during renal biopsy

VR Arm

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • \- Patients age 5-17 receiving a renal biopsy at the University of California, San Francisco (UCSF) Benioff Children's Hospital

You may not qualify if:

  • Patients who cannot lie supine for their renal biopsy will be excluded from the study
  • Patients with injuries to the head/face that would prohibit wearing a headset
  • Patients with loss of consciousness, altered mental status, life-threatening injuries/illness or multi-trauma
  • Patients with open skin, lice, scabies, or other infectious skin conditions on the head/face
  • Patients with a history of or current symptoms of vertigo
  • Patients who are blind
  • Patients with significant developmental or cognitive delays who may not be able to engage with or tolerate the virtual reality environment, as determined by their parent/caregiver
  • Patients on whom the VR headset does not fit appropriately

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Benioff Children's Hospital

San Francisco, California, 94143, United States

Location

Related Publications (3)

  • Jung MJ, Libaw JS, Ma K, Whitlock EL, Feiner JR, Sinskey JL. Pediatric Distraction on Induction of Anesthesia With Virtual Reality and Perioperative Anxiolysis: A Randomized Controlled Trial. Anesth Analg. 2021 Mar 1;132(3):798-806. doi: 10.1213/ANE.0000000000005004.

    PMID: 32618627BACKGROUND
  • Taylor JS, Chandler JM, Menendez M, Diyaolu M, Austin JR, Gibson ML, Portelli KI, Caruso TJ, Rodriguez S, Chao SD. Small surgeries, big smiles: using virtual reality to reduce the need for sedation or general anesthesia during minor surgical procedures. Pediatr Surg Int. 2021 Oct;37(10):1437-1445. doi: 10.1007/s00383-021-04955-6. Epub 2021 Jul 16.

    PMID: 34269867BACKGROUND
  • Goldman RD, Behboudi A. Virtual reality for intravenous placement in the emergency department-a randomized controlled trial. Eur J Pediatr. 2021 Mar;180(3):725-731. doi: 10.1007/s00431-020-03771-9. Epub 2020 Aug 10.

    PMID: 32779029BACKGROUND

Related Links

MeSH Terms

Conditions

Pain, Procedural

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Limitations include selection bias for those who want to participate in VR experience and also the team's inability to blind participants/providers. In addition, the selection of an appropriate VR environment is challenging for various procedures and age groups.

Results Point of Contact

Title
Omar Salman, MD
Organization
University of California, San Francisco

Study Officials

  • Justin Libaw, MD, MPH

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2021

First Posted

March 4, 2022

Study Start

October 11, 2022

Primary Completion

September 8, 2024

Study Completion

September 10, 2024

Last Updated

March 12, 2026

Results First Posted

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations